Human Genome Epidemiology Literature Finder
Records 1 - 27 (of 27 Records) |
Query Trace: Body Weight and CYP2D6[original query] |
---|
The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients. Journal of clinical psychopharmacology 2002 Aug 22 (4): 371-8. Shimoda Kazutaka, Someya Toshiyuki, Yokono Aya, Morita Sachiyo, Hirokane Genta, Takahashi Saburo, Okawa Masa |
The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. Clinical pharmacology and therapeutics 2002 Oct 72 (4): 438-52. Brockmöller Jürgen, Kirchheiner Julia, Schmider Jürgen, Walter Silke, Sachse Christoph, Müller-Oerlinghausen Bruno, Roots Iv |
The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients. Journal of clinical psychopharmacology 2001 Dec 21 (6): 549-55. Yokono A, Morita S, Someya T, Hirokane G, Okawa M, Shimoda |
Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio. Progress in neuro-psychopharmacology & biological psychiatry 2003 Sep 27 (6): 945-9. Ohara Koichi, Tanabu Shigeru, Yoshida Kimiko, Ishibashi Kazuhisa, Ikemoto Keiko, Shibuya Har |
Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia. Therapeutic drug monitoring 2003 Jun 25 (3): 287-93. Mihara Kazuo, Kondo Tsuyoshi, Yasui-Furukori Norio, Suzuki Akihito, Ishida Masayuki, Ono Shingo, Kubota Takahiro, Iga Tatsuji, Takarada Yutaka, de Vries Ronald, Kaneko Sun |
Effects of age and the CYP2D6*10 allele on the plasma haloperidol concentration/dose ratio. Progress in neuro-psychopharmacology & biological psychiatry 2003 May 27 (3): 347-50. Ohara Koichi, Tanabu Shigeru, Ishibashi Kazuhisa, Ikemoto Keiko, Yoshida Kimiko, Shibuya Har |
CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects. European journal of clinical pharmacology 2003 Feb 58 (10): 659-61. Ohara Koichi, Tanabu Shigeru, Ishibashi Kazuhisa, Ikemoto Keiko, Yoshida Kimiko, Shibuya Har |
Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients. European journal of clinical pharmacology 2006 Sep 62 (9): 721-6. Varsaldi Federica, Miglio Gianluca, Scordo Maria Gabriella, Dahl Marja-Liisa, Villa Laura Maria, Biolcati Aldo, Lombardi Graz |
Risperidone-related weight gain: genetic and nongenetic predictors. Journal of clinical psychopharmacology 2006 Apr 26 (2): 128-34. Lane Hsien-Yuan, Liu Yi-Ching, Huang Chieh-Liang, Chang Yue-Cune, Wu Po-Lun, Lu Chung-Ta, Chang Wen- |
Population pharmacokinetics of R- and S-carvedilol in Japanese patients with chronic heart failure. Biological & pharmaceutical bulletin 2010 33 (8): 1378-84. Saito Masako, Kawana Junichi, Ohno Tetsuro, Hanada Kazuhiko, Kaneko Masahiro, Mihara Kiyoshi, Shiomi Mari, Nagayama Masatoshi, Sumiyoshi Tetsuya, Ogata Hiroya |
CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysis. Pharmacogenetics and genomics 2012 Aug . Doki K, Homma M, Kuga K, Aonuma K, Kohda Y |
Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response. Journal of clinical psychopharmacology 2012 Aug 32 (4): 441-8. Lee Seung-Tae, Ryu Seunghyong, Kim Suk-Ran, Kim Min-Ji, Kim Seonwoo, Kim Jong-Won, Lee Soo-Youn, Hong Kyung S |
Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity. Drug metabolism and pharmacokinetics 2015 Aug 30 (4): 257-62. Doki Kosuke, Sekiguchi Yukio, Kuga Keisuke, Aonuma Kazutaka, Homma Masa |
Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients. Pharmacopsychiatry 2015 Nov 48 (7): 279-85. Hayashi Y, Watanabe T, Aoki A, Ishiguro S, Ueda M, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda |
Fast Versus Slow Strategy of Switching Patients With Schizophrenia to Aripiprazole From Other Antipsychotics. Journal of clinical psychopharmacology 2015 Oct . Hwang Tzung-Jeng, Lo Wei-Ming, Chan Hung-Yu, Lin Ching-Feng, Hsieh Ming H, Liu Chen-Chun, Liu Chih-Min, Hwu Hai-Gwo, Kuo Ching-Hua, Chen Wei |
Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis. Pharmacogenetics and genomics 2016 May . Nishimura Miki, Ueda Mikito, Saruwatari Junji, Nakashima Hiroo, Ogusu Naoki, Aoki Akiko, Tsuchimine Shoko, Matsuda Kazuki, Iwashita Kazuma, Ono Tatsumasa, Oniki Kentaro, Shimoda Kazutaka, Yasui-Furukori Nor |
Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental & clinical pharmacology 2016 Apr 30 (2): 153-61. de Moraes Natália V, Lauretti Gabriela R, Coelho Eduardo B, Godoy Ana Leonor P C, Neves Daniel V, Lanchote Vera |
Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms. Annals of clinical biochemistry 2016 Dec . Akamine Yumiko, Sugawara-Kikuchi Yuka, Uno Tsukasa, Shimizu Tetsuo, Miura Masato |
Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment. Pharmacogenetics and genomics 2017 9 27 (11): 402-409. Marcath Lauren A, Deal Allison M, Van Wieren Emily, Danko William, Walko Christine M, Ibrahim Joseph G, Weck Karen E, Jones David R, Desta Zeruesenay, McLeod Howard L, Carey Lisa A, Irvin William J, Hertz Daniel |
Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder. Basic & clinical pharmacology & toxicology 2018 Jan . Sukasem Chonlaphat, Vanwong Natchaya, Srisawasdi Pornpen, Ngamsamut Nattawat, Nuntamool Nopphadol, Hongkaew Yaowaluck, Puangpetch Apichaya, Chamkrachangpada Bhunnada, Limsila Penkh |
Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression. Therapeutic drug monitoring 2020 Dec . Komahashi-Sasaki Hazuki, Yasui-Furukori Norio, Sasaki Taro, Shinozaki Masataka, Hayashi Yuki, Kato Kazuko, Inoue Yoshimasa, Tsuchimine Shoko, Watanabe Takashi, Sugawara Norio, Shimoda Kazuta |
Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer. Clinical pharmacology and therapeutics 2020 Oct . Puszkiel Alicja, Arellano Cécile, Vachoux Christelle, Evrard Alexandre, Le Morvan Valérie, Boyer Jean-Christophe, Robert Jacques, Delmas Caroline, Dalenc Florence, Debled Marc, Venat-Bouvet Laurence, Jacot William, Dohollou Nadine, Bernard-Marty Chantal, Laharie-Mineur Hortense, Filleron Thomas, Roché Henri, Chatelut Etienne, Thomas Fabienne, White-Koning Melan |
Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients. Frontiers in medicine 2021 9 8 683498. Chan Sze Wa, Chu Tanya T W, Ho Chung Shun, Kong Alice P S, Tomlinson Brian, Zeng Weiw |
A Population Pharmacokinetic Meta-Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients. Journal of clinical pharmacology 2021 Apr . Stodtmann Sven, Nuthalapati Silpa, Eckert Doerthe, Kasichayanula Sreeneeranj, Joshi Rujuta, Bach Bruce A, Mensing Sven, Menon Rajeev, Xiong H |
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study. BMC medicine 2022 7 20 (1): 261. Ricardo-Silgado Maria L, Singh Sneha, Cifuentes Lizeth, Decker Paul A, Gonzalez-Izundegui Daniel, Moyer Ann M, Hurtado Maria D, Camilleri Michael, Bielinski Suzette J, Acosta Andr |
Understanding inter-individual variability in pharmacokinetics/pharmacodynamics of aripiprazole in children with tic disorders: Individualized administration based on physiological development and CYP2D6 genotypes. Frontiers in pharmacology 2022 12 13 1048498. Xin Yingying, Gao Liuliu, Tuo Yali, Nie Gang, Mei Yan, Chen Chen, Wang Jun, Li Sichan, Sun Dan, Qian Qiaoqiao, Fu Yongli, Wang Yang, Liu Zhishe |
An increase in urinary primaquine and a reduction in urinary primaquine-5,6-orthoquinone in the Thai population with CYP2D6 reduced enzyme function. Heliyon 2024 1 10 (2): e24351. Waritda Pookmanee, Siriwan Thongthip, Mathirut Mungthin, Chonlaphat Sukasem, Jeeranut Tankanitlert, Pajaree Chariyavilaskul, Supeecha Wittayalertpan |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: